Logo

NEWSBRIEF: Syrrx Sues Oculus for Patent Infringement

May 01, 2002

NEW YORK, May 1 - Syrrx today said it has filed a patent-infringement suit against Oculus Pharmaceuticals.

 

The suit, filed in the US District Court of Delaware, claims that Oculus used certain "nanovolume technologies" patented by Syrrx.

 

Click here for more information.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.